Article info
PDFOriginal research
Long COVID following mild SARS-CoV-2 infection: characteristic T cell alterations and response to antihistamines
- Correspondence to Dr Rajeev Gupta, Stem Cell Laboratory, UCL Cancer Institute, London, UK; rajeev.gupta{at}ucl.ac.uk
Citation
Long COVID following mild SARS-CoV-2 infection: characteristic T cell alterations and response to antihistamines
Publication history
- Accepted August 25, 2021
- First published October 5, 2021.
Online issue publication
December 23, 2021
Article Versions
- Previous version (5 October 2021).
- You are viewing the most recent version of this article.
Supplementary Data
This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.
Supplementary Data
This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© American Federation for Medical Research 2022. Re-use permitted under CC BY-NC. No commercial re-use. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, an indication of whether changes were made, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.